Cosmetic Treatment in Patients with Autoimmune Connective Tissue Diseases. Part I. Best Practices for Patients with Morphea/Systemic Sclerosis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2019.12.081
Abstract: UNSTRUCTURED ABSTRACT Morphea and systemic sclerosis are inflammatory, sclerosing disorders. Morphea primarily affects the dermis and subcutaneous fat, while systemic sclerosis typically involves the skin and internal organs. Functional impairment and cosmetic disfigurement are common… read more here.
Keywords: sclerosis; treatment patients; morphea systemic; systemic sclerosis ... See more keywords